SCAP and metabolic dysfunction-associated steatohepatitis: For example, liver-specific PTEN deficiency results in excess lipids and steatosis in mice, whereas when combined with SCAP deletion it reduces steatosis, exacerbates the later-stage development of inflammation and liver injury, and accelerates the development of NASH and HCC [90].